Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-002010
Filing Date
2025-03-18
Accepted
2025-03-18 16:28:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5488
  Complete submission text file 0001950047-25-002010.txt   7176
Mailing Address C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Nichols William Garrett (Reporting) CIK: 0001618364 (see all company filings)

Type: 144

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Subject) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40629 | Film No.: 25748828
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)